1. Introduction

Liability for damage to leased biological material concerns the legal responsibility arising when biological substances, organisms, tissues, cells, genetic samples, reproductive material, microorganisms, laboratory cultures, seeds, or other biological resources are damaged, destroyed, contaminated, improperly handled, or rendered unusable while in the possession or control of a person who has received them under a lease or similar contractual arrangement.

This subject is particularly important in modern biotechnology, medical research, pharmaceutical manufacturing, agricultural science, genetic engineering, reproductive medicine, and biological laboratories.

Unlike ordinary commercial goods, biological materials may possess special characteristics:

They may be living organisms capable of growth and reproduction.

They may deteriorate rapidly without appropriate storage.

They may be genetically unique or scientifically irreplaceable.

They may create risks of infection, contamination, or ecological harm.

Their destruction may result in financial loss, scientific loss, or harm to human health.

Their use and transfer may be restricted by statutory and ethical requirements.

The central legal question is: Who should bear responsibility when biological material supplied under a lease is damaged during the lease period?

The answer generally depends on the contractual terms, the nature of the biological material, the degree of control exercised by the lessee, the cause of damage, applicable statutory duties, and the foreseeability of the resulting loss.

An important distinction is that a transaction described commercially as a lease may legally constitute a bailment, licence, custody arrangement, or transfer of possession rather than a conventional lease of immovable property.

2. Legal nature of leased biological material

Before determining liability, it is necessary to identify the legal nature of the transaction.

A. Biological material as leased property

A biological material may be supplied to a laboratory, research institution, university, pharmaceutical company, or agricultural organisation for temporary use.

Examples include:

Living bacterial and viral cultures supplied for research.

Genetically modified plants and experimental seeds.

Laboratory animals supplied for scientific testing.

Frozen sperm, eggs, embryos, and reproductive cells.

Human tissue samples and established cell lines.

Microorganisms supplied for pharmaceutical production.

Biological specimens maintained in specialised storage facilities.

The recipient may have permission to use the material for a specified period without acquiring unrestricted ownership.

B. Bailment rather than conventional lease

Under Indian law, many arrangements involving the delivery of movable biological material are more appropriately analysed as bailment under Section 148 of the Indian Contract Act, 1872.

The parties are:

Bailor: The person or institution delivering the biological material.

Bailee: The person or institution receiving and possessing it.

Bailed property: The biological material entrusted for a particular purpose.

The bailee must return the material, or deal with it according to the bailor's directions, when the agreed purpose is completed.

A transaction does not become a conventional lease merely because the agreement uses the word lease.

C. Ownership and possession are different

The original owner may retain ownership while the recipient obtains temporary possession and limited rights of use.

For example, a biotechnology company may provide a genetically modified bacterial strain to a research laboratory for a six-month experimental project.

The laboratory may have permission to conduct approved experiments but may not have permission to:

Sell the strain.

Transfer it to another laboratory.

Genetically modify it beyond the authorised scope.

Release it into the environment.

Commercialise derivatives without permission.

Destroy or permanently retain the original culture.

Unauthorised conduct may constitute breach of contract, breach of bailment obligations, or other statutory violations.

3. Legal framework under Indian law

The Indian Contract Act, 1872 provides the principal contractual framework for determining liability.

A. Section 148 – Definition of bailment

Section 148 defines bailment as delivery of goods by one person to another for a particular purpose, under an agreement that the goods will be returned or otherwise dealt with according to the deliverer's directions.

Application:

Where biological material is delivered to a research institution for temporary possession and use, Section 148 may govern the relationship.

The essential elements are:

Delivery of possession.

Existence of a contractual or legally recognised arrangement.

A specified purpose.

An obligation to return or otherwise dispose of the material as directed.

The important issue is whether the particular biological material qualifies as legally transferable movable property. This is relatively straightforward for commercial biological cultures and certain biological products, but more complicated for human tissues, reproductive material, and other human-derived samples.

B. Section 150 – Bailor's duty to disclose defects

Section 150 imposes an obligation on the bailor to disclose defects that materially interfere with the intended use of the goods or expose the recipient to extraordinary risks.

Where goods are bailed for hire, the bailor is responsible for damage arising from such defects even if the bailor did not know about them.

Example:

A biotechnology company leases a bacterial culture to a pharmaceutical laboratory. The culture contains an undisclosed contaminant that makes it unsuitable for the agreed research.

If the contamination causes damage to the laboratory's experimental process, the supplying company may be liable under Section 150.

This provision is particularly important where biological material has latent defects, including:

Undetected microbial contamination.

Genetic instability.

Incorrect species identification.

Unexpected pathogenic characteristics.

Inadequate preservation.

Defective storage or transport before delivery.

C. Section 151 – Duty of reasonable care

Section 151 requires a bailee to take as much care of the bailed goods as a person of ordinary prudence would take of goods of similar bulk, quality, and value under similar circumstances.

India Code+1

In the biological-material context, reasonable care may require:

Maintaining prescribed temperature conditions.

Using suitable sterilisation procedures.

Preventing cross-contamination.

Maintaining appropriate humidity and oxygen levels.

Monitoring storage equipment.

Maintaining biological safety protocols.

Keeping accurate storage and handling records.

Preventing unauthorised access.

Following the manufacturer's preservation instructions.

The standard of care must reflect the nature of the material. A highly sensitive frozen embryo or genetically unstable microbial culture requires different precautions from ordinary commercial goods.

D. Section 152 – When the bailee is not liable

Section 152 provides that, in the absence of a special contract, a bailee is not liable for loss, destruction, or deterioration if the bailee has exercised the degree of care prescribed under Section 151.

Indian Kanoon+1

Example:

A research laboratory stores a leased biological culture under all prescribed conditions. An extraordinary natural disaster destroys the storage facility despite reasonable preventive measures.

The laboratory may escape liability under Section 152, depending on the contractual allocation of risk and the circumstances.

However, merely describing an event as an accident or force majeure does not automatically eliminate liability.

E. Section 153 – Termination for inconsistent conduct

Section 153 allows the bailor to terminate the bailment where the bailee acts inconsistently with the conditions of the arrangement.

For example, a laboratory receives a biological sample exclusively for diagnostic research but transfers it to an unrelated commercial enterprise.

The owner may terminate the arrangement and seek appropriate contractual remedies.

F. Section 154 – Unauthorised use

Section 154 makes the bailee liable for damage arising from or during unauthorised use of the bailed material.

Examples include:

Using a leased microbial culture for a different experiment.

Subjecting leased animals to unauthorised procedures.

Using reproductive material for an unapproved purpose.

Conducting unapproved genetic modifications.

Transferring a biological sample to an unauthorised third party.

Even where the damage is accidental, unauthorised use may establish liability.

G. Sections 160 and 161 – Failure to return material

Section 160 requires the bailee to return the material when the agreed period expires or the specified purpose is accomplished.

Section 161 makes the bailee responsible for loss, destruction, or deterioration resulting from default in returning the material at the proper time.

IndiaCode+1

For example, a laboratory that retains a leased biological culture beyond the contractual period may be responsible for its subsequent deterioration if the delay causes the loss.

H. Section 163 – Increase or profit from bailed goods

Section 163 provides that, unless the parties agree otherwise, the bailee must deliver to the bailor any increase or profit arising from the bailed goods.

This is particularly interesting in biological-material transactions.

Suppose a laboratory receives a living microbial culture and, during authorised maintenance, the culture multiplies.

The legal entitlement to the resulting increase may depend on Section 163, the nature of the material, the contract, intellectual property rights, applicable biosafety restrictions, and any separate material-transfer agreement.

It does not automatically mean that every newly developed biological invention belongs to the original supplier.

4. Important judicial precedents and case laws

The following decisions provide relevant principles concerning bailment, property, biological material, and responsibility for damage. Some are directly concerned with biological material, while others provide general legal principles applicable by analogy.

Case 1. State of Gujarat v. Memon Mahomed Haji Hasam (1967)

Supreme Court of India

Citation: AIR 1967 SC 1885; (1967) 3 SCR 938.

Facts:

The case concerned the seizure and subsequent handling of vehicles by government authorities. The vehicles were taken into custody and subsequently dealt with in circumstances giving rise to a dispute concerning their loss and deterioration.

Legal issue:

Whether a person or authority that takes possession of another person's property can incur obligations similar to those of a bailee even without a conventional contractual bailment.

Judgment and principle:

The Supreme Court recognised that when the State takes possession of private property, it may assume obligations analogous to those of a bailee.

The absence of a formally executed bailment contract does not necessarily eliminate the duty to take reasonable care of property entrusted to its custody.

Application to leased biological material:

Where a government laboratory, research institution, or public biotechnology facility takes custody of another party's biological material, it may be required to exercise reasonable care.

For example, if a government research centre receives privately owned biological cultures and damages them through negligent storage, the principles of this judgment may support a claim based on custodial responsibility.

Case 2. Union of India v. Udho Ram & Sons

Legal principle: Liability relating to goods entrusted to another party and the obligations arising from custody.

This line of bailment jurisprudence is relevant when assessing the responsibilities of custodians, transporters, and institutions handling property belonging to another person.

Application:

A company receiving leased biological material cannot necessarily avoid responsibility by arguing that it was merely storing the material rather than actively using it.

Its actual custody, contractual duties, and negligence remain relevant.

Note: This is a supplementary general bailment reference; the statutory provisions and the Supreme Court's decision in Memon Mahomed Haji Hasam provide the stronger foundation for the present subject.

Case 3. Yearworth and Others v. North Bristol NHS Trust (2009)

Court of Appeal of England and Wales

Citation: [2009] EWCA Civ 37; [2010] QB 1.

Directly relevant biological-material precedent

Facts:

Six men suffering from cancer were advised that chemotherapy could damage their fertility.

Before undergoing treatment, they deposited semen samples with a hospital for freezing and preservation so that they could potentially use the sperm in the future.

The hospital undertook to preserve the samples in liquid nitrogen at approximately minus 196°C.

However, the liquid nitrogen level fell below the required level, and the automatic replenishment system was not functioning. The hospital failed to replenish the tanks manually.

Consequently, the sperm samples thawed and became unusable.

The men brought legal proceedings against the hospital.

Legal issues:

Whether the hospital owed a duty of care concerning the stored sperm.

Whether the sperm could constitute property belonging to the men.

Whether the hospital was liable under the law of bailment.

Whether compensation could be claimed for the loss.

Judgment:

The Court of Appeal recognised that the men had ownership rights in their stored sperm for the purposes of their negligence claims.

It also held that a bailment relationship existed between the men and the hospital.

The hospital had assumed responsibility for preserving the biological material and had failed to fulfil its undertaking.

The court recognised that liability could arise under both negligence and bailment principles.

Legal principle:

A person or institution accepting possession of biological material for preservation may become legally responsible for its proper care. The destruction of biological material through negligent storage can give rise to actionable liability.

Application to leased biological material:

This is one of the most significant decisions for the present subject.

Suppose a biotechnology company leases a genetically valuable cell line to a research laboratory. The laboratory agrees to preserve it under specified conditions.

If the laboratory negligently fails to maintain the required temperature and destroys the cell line, the reasoning in Yearworth supports the argument that the recipient may be liable for breach of its custodial obligations.

The case is particularly relevant to:

Frozen reproductive material.

Human cell cultures.

Biological research specimens.

Cryopreserved tissues.

Specialised biological storage.

Scientifically valuable biological resources.

However, the English judgment is persuasive rather than binding in Indian courts.

Bailii+1

Case 4. Moore v. Regents of the University of California (1990)

Supreme Court of California, USA

Citation: 51 Cal. 3d 120; 793 P.2d 479 (1990).

Facts:

John Moore was treated for hairy-cell leukaemia. During his treatment, doctors removed his spleen and collected other biological samples.

Researchers discovered that his cells possessed unusual characteristics and developed a commercially valuable cell line.

The researchers obtained patents and entered into commercial arrangements without properly disclosing their research and financial interests to Moore.

Moore subsequently challenged the use and commercial exploitation of his biological material.

Legal issues:

Whether an individual retains proprietary rights in removed biological material.

Whether researchers may commercially exploit human tissue without appropriate disclosure.

Whether the doctors breached their professional obligations.

Judgment:

The California Supreme Court rejected Moore's conversion claim based on ownership of the excised cells under the circumstances of the case.

However, it recognised that the failure to disclose relevant research and financial interests could support claims for breach of fiduciary duty and lack of informed consent.

Legal principle:

The legal treatment of human biological material is not identical to that of ordinary commercial property. Consent, disclosure, medical ethics, and the circumstances of removal are important.

Application to leased biological material:

Suppose a medical research institution receives human-derived biological samples under an arrangement permitting limited research.

It subsequently uses the samples for unauthorised commercial research or transfers them to another company.

The institution may face liability for breach of contractual restrictions, lack of consent, breach of confidentiality, or other applicable obligations.

However, Moore does not establish that every human biological sample is freely transferable property or that all commercial use is prohibited.

The decision demonstrates why ownership, possession, consent, and permissible use must be analysed separately.

Justia Law+1

Case 5. Greenberg v. Miami Children's Hospital Research Institute (2003)

Citation: 264 F. Supp. 2d 1064 (S.D. Fla. 2003).

Court: United States District Court, Southern District of Florida.

Facts:

Parents of children affected by Canavan disease contributed biological materials and research assistance to help researchers identify the genetic cause of the disease.

A researcher subsequently isolated and patented the relevant gene sequence and developed genetic screening tests.

The contributors challenged the researcher's conduct and commercialisation of the research.

Legal issue:

Whether individuals who contribute biological materials and research assistance acquire proprietary rights or other legal claims relating to subsequent scientific discoveries and commercial exploitation.

Judgment:

The court rejected the conversion claim in relation to the donated biological materials and considered the legal limitations on the contributors' claims to the resulting research and intellectual property.

The decision illustrates the distinction between rights in contributed biological samples and rights in subsequent scientific discoveries.

Application to leased biological material:

Where a research laboratory receives leased biological material, the agreement should expressly determine:

Ownership of the original sample.

Ownership of replicated cultures.

Rights over genetically modified derivatives.

Commercialisation rights.

Rights over research findings.

Obligations concerning destruction or return.

A party cannot automatically claim ownership of every scientific discovery simply because it supplied the original biological material.

PubMed

Case 6. Doodeward v. Spence (1908)

Citation: (1908) 6 CLR 406.

Court: High Court of Australia.

Facts:

The dispute concerned the possession of a preserved human body specimen.

The question was whether human remains could acquire a proprietary character under circumstances involving preservation and the application of skill.

Judgment:

The court recognised that human remains could, in certain circumstances, acquire a legally recognisable proprietary character where work or skill had been applied to them so that they acquired attributes different from an ordinary corpse.

Legal principle:

Biological material may acquire a legally recognisable property character through preservation, processing, or scientific treatment, depending on the applicable legal system and circumstances.

Application:

A scientifically preserved biological specimen, specially processed cell line, or laboratory culture may be treated differently from unprocessed human remains.

This principle is relevant when determining whether the leased material can be the subject of proprietary and possessory rights.

The decision must, however, be applied cautiously, particularly to human tissue and reproductive material.

Case 7. Washington University v. Catalona (2007)

Citation: 490 F.3d 667 (8th Cir. 2007).

Court: United States Court of Appeals for the Eighth Circuit.

Facts:

Dr. William Catalona collected prostate tissue samples from patients for research at Washington University.

A dispute arose concerning the control and transfer of the stored biological samples when the doctor moved to another institution.

Legal issue:

Whether the patients who donated biological specimens retained the right to direct their transfer to another research institution, or whether the university controlled the repository.

Judgment:

The court upheld the university's control over the samples in the circumstances of the donations and the relevant agreements.

Application:

This decision demonstrates that the legal status of biological samples depends heavily on the terms of collection, consent, custody, and institutional arrangements.

For leased biological material, a carefully drafted agreement should specify whether the recipient has mere custody, limited possession, or broader rights to use and transfer the material.

It also highlights the importance of distinguishing a donor's rights from an institution's custodial rights.

5. Grounds on which liability may arise

Liability for damage to leased biological material may arise in several different ways.

A. Negligent storage

This is one of the most common grounds.

Examples:

Failure to maintain cryogenic temperatures.

Failure to monitor storage equipment.

Improper refrigeration.

Inadequate sterilisation.

Failure to maintain humidity.

Failure to monitor biological viability.

Legal consequence: The lessee may be liable for breach of Section 151 of the Indian Contract Act, breach of contract, and negligence.

The reasoning in Yearworth v. North Bristol NHS Trust is particularly relevant.

B. Biological contamination

Contamination occurs when foreign biological substances enter the leased material.

For example, a research institution leases a bacterial culture for pharmaceutical research. Due to poor laboratory practices, another microorganism enters the culture and destroys its original characteristics.

Potential liability may arise from:

Failure to maintain laboratory hygiene.

Failure to separate biological samples.

Improper sterilisation.

Negligent handling.

Failure to follow biosafety procedures.

The lessee may be liable if the contamination resulted from its breach of duty.

However, if the material was already contaminated before delivery, the supplier's liability under Section 150 may become relevant.

C. Genetic alteration or mutation

Biological materials may undergo genetic changes during storage, experimentation, or reproduction.

For example, a laboratory receives a genetically modified organism for a specified research project. Without authorisation, it subjects the organism to additional genetic modifications.

If the modifications destroy the original characteristics or make the material unusable, the laboratory may be liable for unauthorised use and breach of contract.

Relevant legal principles include:

Section 154 of the Indian Contract Act.

Contractual restrictions on modification.

Applicable biotechnology regulations.

Intellectual property rights.

Biosafety requirements.

Not every naturally occurring mutation creates liability. The cause, foreseeability, contractual allocation of risk, and reasonable precautions must be examined.

D. Destruction of biological material

Complete destruction is the most serious form of damage.

Examples include:

Accidental destruction of frozen embryos.

Death of leased laboratory animals through negligence.

Destruction of genetically unique seeds.

Loss of irreplaceable cell lines.

Death of living microbial cultures.

Liability depends on the responsible party's contractual and legal obligations.

Where the destruction results from negligence, the lessee may be required to compensate the owner for the legally recoverable loss.

E. Unauthorised transfer

A lessee may transfer biological material to another institution without permission.

This may violate:

Contractual restrictions.

Material Transfer Agreements.

Confidentiality obligations.

Consent requirements.

Biosafety regulations.

The original owner may seek termination of the arrangement, return or destruction of the material where legally permissible, an injunction, and damages.

F. Failure to return biological material

A lessee may retain biological material after expiry of the lease.

If the material deteriorates because it was not returned at the agreed time, Section 161 may become applicable.

A particular difficulty arises where the material is perishable or has a limited viable storage period.

The lessee cannot ordinarily avoid responsibility merely by asserting that the biological material would eventually have deteriorated anyway. The claimant must establish the relevant breach and causation.

6. Special legal considerations concerning biological material in India

Damage to leased biological material may involve legislation beyond the Indian Contract Act.

A. Indian Council of Medical Research (ICMR) Ethical Guidelines, 2017/2018

The ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants contain important provisions concerning biological materials, biobanking, and datasets.

Section 11 addresses:

Ownership of biological samples.

Transfer of biospecimens.

Custodianship.

Secondary use of biological material.

Informed consent.

Commercial value and benefit sharing.

Privacy and confidentiality.

Material Transfer Agreements.

The guidelines recognise the distinction between ownership of samples by participants and the custodial responsibilities of biobanks and research institutions.

They also recommend Material Transfer Agreements where biospecimens are transferred to collaborators, including international collaborators.

Legal significance:

Where leased or entrusted human biological material is damaged, the parties' contractual duties should be interpreted alongside the applicable ethical and regulatory obligations.

The guidelines are important ethical and institutional standards, although they should not automatically be treated as an independent statutory cause of action in every dispute.

Indian Council of Medical Research+1

B. Environment (Protection) Act, 1986

This legislation provides the statutory framework for environmental protection.

Its importance increases where leased biological material involves genetically engineered organisms, hazardous microorganisms, or potentially harmful biological agents.

Relevant provisions include:

Section 3: Power of the Central Government to take measures to protect and improve the environment.

Section 5: Power to issue directions.

Section 6: Power to make rules regulating environmental pollution.

The Environment (Protection) Rules, 1986 and the rules governing hazardous microorganisms and genetically engineered organisms may also become relevant.

Example:

A laboratory leases a genetically modified microorganism but negligently allows it to escape into the surrounding environment.

The matter may involve contractual liability as well as statutory environmental and biosafety consequences.

C. Biological Diversity Act, 2002

The Biological Diversity Act regulates access to biological resources, associated knowledge, and certain related activities.

It may become relevant where the leased material consists of biological resources obtained from India and the transaction involves regulated access, research, transfer, or commercial utilisation.

However, the Act is not a general compensation statute for every instance of damage to leased biological material.

Its applicability depends on the biological resource, the parties, the nature of the transaction, and the relevant statutory exemptions and regulatory requirements.

D. Assisted Reproductive Technology (Regulation) Act, 2021

This legislation is important where the biological material involves reproductive cells, gametes, embryos, and assisted reproductive technology services.

A commercial lease analogy should not be used to bypass the special legal and ethical framework governing human reproductive material.

Relevant issues include:

Consent.

Storage and preservation.

Permitted use.

Rights and responsibilities of ART banks.

Regulatory compliance.

Confidentiality and recordkeeping.

A dispute concerning destruction of stored reproductive material therefore requires examination of both general civil liability and the specialised statutory framework.

7. Who can be held liable?

The following parties may potentially bear responsibility depending on their conduct and contractual obligations.

Liability may be shared where multiple parties contributed to the damage.

For example, the supplier may have provided defective preservation instructions, while the recipient may also have failed to monitor storage conditions.

The court must determine the contribution of each party to the actual loss.

8. Types of damages and compensation

Where liability is established, several categories of compensation may be available.

A. Replacement value

The owner may claim the reasonable value of the damaged biological material.

This is relatively straightforward where the material is commercially available.

B. Restoration and preservation expenses

Compensation may include reasonable costs of:

Recovering damaged cultures.

Reconstructing biological samples.

Repeating preservation procedures.

Re-establishing a laboratory culture.

Conducting viability tests.

C. Loss of scientific value

Some biological material has specialised scientific value because of its unique genetic characteristics or research history.

For example, destruction of an irreplaceable genetically characterised cell line may cause losses beyond the ordinary market price of laboratory materials.

Such claims require reliable scientific and financial evidence.

D. Loss of commercial opportunities

Where destruction prevents a company from fulfilling a pharmaceutical or biotechnology contract, it may claim foreseeable and legally recoverable commercial losses.

However, speculative profits are not automatically recoverable.

E. Consequential damages

These may include additional losses directly attributable to the breach, subject to the applicable rules of causation, remoteness, and contractual limitations.

F. Mental distress and personal consequences

Where the material involves reproductive cells or other human-derived specimens, destruction may have serious personal consequences.

The recoverability of damages for mental distress depends on the applicable law, the nature of the duty, and the evidence.

The reasoning in Yearworth is especially relevant because the Court of Appeal recognised the possibility of recovery for certain foreseeable psychiatric injuries or actionable distress under the particular arrangements.

It should not be assumed that every loss of biological material automatically creates an entitlement to mental-distress compensation.

9. Defences available to the lessee

A lessee facing a claim for damage to biological material may rely on several defences.

1. Exercise of reasonable care

Under Section 152, the bailee may avoid liability where the required standard of care under Section 151 was exercised and no special contractual obligation changes the position.

2. Pre-existing defects

The lessee may demonstrate that the material was defective or contaminated before delivery.

Section 150 may then become relevant to the supplier's responsibility.

3. Force majeure

An extraordinary event may provide a defence where the contract and applicable law permit it and the event genuinely caused the loss despite appropriate precautions.

4. Natural biological deterioration

Some biological materials have an inherent limited lifespan. The lessee may argue that deterioration was natural and not attributable to negligence.

5. Contributory conduct

The owner may have supplied inaccurate storage instructions, failed to disclose known defects, or contributed to the damage.

6. Contractual allocation of risk

The parties may have agreed on particular risks, liability limits, insurance arrangements, or exclusions.

However, contractual exclusions cannot necessarily override mandatory statutory duties or protect conduct that the applicable law does not permit the parties to exclude.

10. Evidence required to establish liability

Scientific evidence is particularly important in these disputes.

A claimant should ideally establish the following:

The claimant generally needs to establish the relevant duty, breach, causation, and legally recognised loss.

A laboratory's failure to produce records may be significant in assessing its compliance with contractual and regulatory responsibilities, although the evidentiary consequences depend on the applicable procedural law.

11. Illustrative legal situations

The following examples demonstrate how the principles operate.

Situation 1: Destruction of leased bacterial cultures

A pharmaceutical company leases a specialised bacterial culture to a research laboratory for six months.

The laboratory fails to maintain the prescribed temperature, causing the culture to die.

Likely legal consequences:

Breach of Section 151.

Possible liability under Section 152 where the bailee cannot establish the statutory defence.

Breach of the lease or bailment agreement.

Compensation for the proven value and foreseeable consequential losses.

Situation 2: Damage to leased reproductive material

A fertility institution accepts responsibility for preserving reproductive material but negligently allows the storage system to fail.

The material becomes unusable.

Likely legal consequences:

The reasoning in Yearworth v. North Bristol NHS Trust may be relevant to determining custodial responsibility, negligence, bailment, and damages.

In India, the Assisted Reproductive Technology (Regulation) Act, 2021 and applicable regulatory requirements must also be considered.

Situation 3: Unauthorised genetic modification

A biotechnology company leases a genetically modified organism for a specified research purpose.

The receiving laboratory makes unauthorised genetic alterations, destroying the original strain's characteristics.

Likely legal consequences:

Breach of contractual restrictions.

Liability under Section 154 where the unauthorised use causes damage.

Possible intellectual property disputes.

Potential biosafety and environmental regulatory consequences.

Situation 4: Contamination during storage

A research institution leases a valuable biological specimen and stores it alongside incompatible biological cultures.

The specimen becomes contaminated.

Likely legal consequences:

The institution may be liable for negligent handling, failure to follow preservation protocols, and breach of its contractual obligations.

Situation 5: Defective material supplied by the owner

A supplier leases a biological culture that already contains an undisclosed contaminant.

The recipient follows all prescribed procedures but the culture becomes unusable.

Likely legal consequences:

Section 150 may impose responsibility on the supplier where the material is bailed for hire and the defect causes the relevant damage.

12. Practical contractual safeguards

A properly drafted biological-material lease or Material Transfer Agreement should contain the following provisions:

Ownership clause: Identifies the legal owner of the original biological material.

Permitted-use clause: Specifies authorised research, commercial, or medical purposes.

Preservation clause: Establishes temperature, humidity, sterilisation, and storage requirements.

Contamination clause: Allocates responsibility for contamination and cross-contamination.

Genetic modification clause: Regulates mutation, modification, replication, and derivatives.

Inspection clause: Allows the owner to inspect storage and handling conditions.

Reporting clause: Requires immediate reporting of deterioration, contamination, or destruction.

Return clause: Specifies how and when the material must be returned.

Insurance clause: Establishes appropriate coverage for biological-material loss.

Indemnification clause: Allocates responsibility for losses caused by contractual or regulatory breaches.

Confidentiality clause: Protects genetic information and associated research data.

Dispute-resolution clause: Establishes jurisdiction, arbitration, and other dispute-resolution mechanisms.

These safeguards are particularly important because ordinary replacement-value provisions may be inadequate for biologically unique or irreplaceable materials.

13. Important case-law summary

14. Conclusion

Liability for damage to leased biological material is an emerging and scientifically complex area of legal responsibility involving contract law, bailment, negligence, property rights, biotechnology regulation, and medical ethics.

Under Indian law, Sections 148–154 and 160–163 of the Indian Contract Act, 1872 provide an important legal foundation for determining the rights and obligations of the owner and recipient.

The most important principles are:

The owner generally retains the rights specified in the agreement, while the recipient obtains only the authorised rights of possession and use.

The recipient must exercise reasonable care over biological material entrusted to it.

Negligent storage, contamination, unauthorised modification, and improper handling may create liability.

The supplier may be responsible for defective biological material under Section 150.

Failure to return the material or its deterioration due to delayed return may attract Section 161.

Human-derived biological material requires additional consideration of consent, dignity, confidentiality, and specialised regulatory requirements.

Compensation must be based on legally recoverable and sufficiently established losses.

The central judicial principle is that a person or institution accepting possession of valuable biological material for a specified purpose cannot disregard the responsibility to preserve it with appropriate care.

The decision in Yearworth v. North Bristol NHS Trust is particularly instructive because it demonstrates that the negligent destruction of stored biological material may give rise to both negligence and bailment claims.

Important qualification: There does not appear to be a directly controlling Indian Supreme Court judgment establishing a comprehensive doctrine specifically for damage to leased biological material. The Indian statutory bailment provisions, general negligence principles, applicable biotechnology regulations, and persuasive foreign precedents must therefore be considered together.

15. Principal legal sources for further study

Indian Contract Act, 1872 – Sections 148–171. India Code – Indian Contract Act.

State of Gujarat v. Memon Mahomed Haji Hasam, AIR 1967 SC 1885.

Yearworth v. North Bristol NHS Trust, [2009] EWCA Civ 37. Full judgment.

Moore v. Regents of the University of California, 51 Cal. 3d 120 (1990). Full judgment.

Greenberg v. Miami Children's Hospital Research Institute, 264 F. Supp. 2d 1064 (2003).

Doodeward v. Spence, (1908) 6 CLR 406.

ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017/2018. ICMR Guidelines – Biological Materials and Biobanking.

This is an academic legal explanation, primarily based on Indian law, with comparative common-law precedents. The applicability of individual provisions depends on the nature of the biological material and the precise contractual arrangement.